Nanotechnology in Targeting Tumor Angiogenesis
Author Information
Author(s): Deboshri Banerjee, Rania Harfouche, Shiladitya Sengupta
Primary Institution: Brigham and Women's Hospital, Harvard Medical School
Hypothesis
Can nanotechnology improve the targeting of tumor-associated angiogenesis for cancer therapy?
Conclusion
Nanotechnology offers significant advantages in targeting tumor angiogenesis, potentially improving the efficacy and safety of cancer therapies.
Supporting Evidence
- Nanoparticles can carry high payloads of therapeutic agents and improve drug half-life.
- Targeting tumor vasculature can reduce systemic toxicity compared to conventional chemotherapy.
- Nanotechnology allows for non-invasive imaging of tumor angiogenesis.
Takeaway
Scientists are using tiny particles to help deliver medicine directly to tumors, making treatments work better and cause fewer side effects.
Methodology
The review discusses various types of nanoparticles and their applications in targeting tumor angiogenesis, including passive and active targeting mechanisms.
Limitations
Many anti-angiogenic therapies still struggle with poor biodistribution and low efficacy due to systemic administration.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website